Javed Anees: An Evidence-Based Clinical Guide to ESA Therapy
Javed Anees, Medical Consultant at Government of Kerala, shared a post on LinkedIn:
“Erythropoiesis-Stimulating Agents (ESAs) have transformed the management of anemia in chronic kidney disease and selected oncology patients by reducing transfusion requirements and improving quality of life. However, appropriate patient selection, correction of reversible causes, and careful monitoring remain essential to maximize benefit while minimizing cardiovascular and thromboembolic risks.
This evidence-based infographic summarizes:
- Indications for ESA therapy
- When to initiate treatment in CKD and dialysis
- Pre-treatment evaluation and iron optimization
- Target hemoglobin and dose adjustment
- Contraindications and adverse effects
- Causes of ESA hyporesponsiveness
- HIF-prolyl hydroxylase inhibitors and other alternatives
- Practical clinical pearls aligned with current guideline recommendations
A key reminder:
ESA therapy should be individualized – not driven by hemoglobin alone. Correct iron deficiency and other reversible causes first, use the lowest effective ESA dose to reduce transfusion needs, and avoid targeting normal hemoglobin levels. In most CKD patients, a hemoglobin around 10–11.5 g/dL is the preferred therapeutic range.
I hope this infographic serves as a concise, practical reference for residents, physicians, nephrologists, internists, and trainees involved in anemia management.”
Other posts featuring Javed Anees on Hemostasis Today.
-
Jul 8, 2026, 19:27Ahmadou Ouedraogo: Do You Know Your Blood Type?
-
Jul 8, 2026, 19:25Paul Breillat: Nature Reviews Rheumatology Highlights Our VEXAS Syndrome Research
-
Jul 8, 2026, 19:25Luca Saba: Why Does the Same Patient Have Different Plaque in Different Arteries?
-
Jul 8, 2026, 19:25Luisa Weiss: Understanding the Molecular Differences Between Acute and Chronic Coronary Syndromes.
-
Jul 8, 2026, 19:11J. Meireles-Brandao: Role of Modifiable Cardiovascular Risk Factors in Dementia Development
-
Jul 8, 2026, 16:58Emmanuel J Favaloro։ Acquired von Willebrand Syndrome: Key Concepts for Clinical Practice
-
Jul 8, 2026, 16:47Arun V. J: Why Healthcare Professionals Need More Than Medical Training
-
Jul 8, 2026, 16:38Mona Alfaraj: What Does This HbA₂ Pattern Suggest?
-
Jul 8, 2026, 16:34Alexandros Tsourpas: One of CIMB’s Top-Performing Papers of 2025